Keyphrases
Progesterone Receptor
100%
Early Onset
100%
Tissue Microarray
100%
Breast Carcinoma
100%
Ki-67
100%
Immunohistochemical Markers
100%
Distant Metastasis
75%
Estrogen Receptor
50%
Early Breast Cancer
50%
B-cell Lymphoma 2 (Bcl-2)
50%
Human Epidermal Growth Factor Receptor 2 (HER2)
50%
Tumor Stage
50%
Biologic Markers
50%
Local Relapse
50%
Nodal Status
50%
Young Breast Cancer
50%
Radiotherapy
25%
Multivariate Analysis
25%
Poor Prognosis
25%
Univariate Analysis
25%
Breast
25%
Overall Survival
25%
Well-defined
25%
Young Women
25%
Young Patients
25%
Relapse-free Survival
25%
Microarray Experiment
25%
Prognostic Factors
25%
Relapse-free
25%
Paraffin-embedded Specimens
25%
Distant Relapse
25%
Local Failure
25%
Conservative Surgery
25%
Biomarker Expression
25%
Distant Failure
25%
Positive Expression
25%
Medicine and Dentistry
Breast Cancer
100%
Progesterone Receptor
100%
Biological Marker
100%
Tissue Microarray
100%
Breast Carcinoma
100%
Distant Metastasis
75%
Estrogen Receptor
50%
Protein P53
50%
Biological Product
50%
Cancer Staging
50%
Radiation Therapy
25%
Multivariate Analysis
25%
Univariate Analysis
25%
Survival Rate
25%
Recurrence Free Survival
25%
Overall Survival
25%
Prognostic Factor
25%
Biochemistry, Genetics and Molecular Biology
Progesterone Receptor
100%
Tissue Microarray
100%
Estrogen Receptor
50%
P53
50%
Cancer Staging
50%
Bcl-2
50%
Multivariate Analysis
25%
Overall Survival
25%
Survival Rate
25%
Recurrence Free Survival
25%